Knights of Columbus Asset Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,040	Closed	-$2.59M	–	339
2021 Q1	$2.59M	Buy	12,040 +389	+3%	+$85.4K	0.25%	137
2020 Q4	$2.75M	Sell	11,651 -3,280	-22%	-$753K	0.29%	116
2020 Q3	$4.06M	Sell	14,931 -1,625	-10%	-$448K	0.5%	51
2020 Q2	$4.81M	Sell	16,556 -286	-2%	-$77.5K	0.59%	35
2020 Q1	$4.01M	Sell	16,842 -1,500	-8%	-$344K	0.51%	47
2019 Q4	$4.02M	Buy	+18,342	New	+$3.71M	0.35%	72
2019 Q3	–	Sell	-4,120	Closed	-$756K	–	149
2019 Q2	$756K	Buy	4,120 +1,262	+44%	+$221K	0.3%	95
2019 Q1	$526K	Buy	2,858 +741	+35%	+$137K	0.21%	112
2018 Q4	$351K	Buy	2,117 +601	+40%	+$104K	0.16%	119
2018 Q3	$292K	Buy	+1,516	New	+$270K	0.12%	127

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Knights of Columbus Asset Advisors's VRTX Position: Q2 2021 in Review

Knights of Columbus Asset Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 12,040 shares — an estimated $2.59M sold.

Knights of Columbus Asset Advisors first reported a position in VRTX in Q3 2018 and held it in 10 quarters. The position peaked at $4.81M in Q2 2020. 977 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

Knights of Columbus Asset Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 12,040 Vertex Pharmaceuticals shares in Q2 2021, an estimated $2.59M.
Knights of Columbus Asset Advisors first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 10 quarters.
Knights of Columbus Asset Advisors's Vertex Pharmaceuticals position peaked at $4.81M in Q2 2020.
977 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.